{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:03:55Z","timestamp":1761059035348},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T00:00:00Z","timestamp":1269561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s10719-010-9287-0","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T10:33:25Z","timestamp":1269513205000},"page":"401-417","source":"Crossref","is-referenced-by-count":14,"title":["Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: chemical strategies to prepare glycoconjugates with good carbohydrate loading"],"prefix":"10.1007","volume":"27","author":[{"given":"Andrew D.","family":"Cox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"St. Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhamodharan","family":"Neelamegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Lacelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantelle","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,26]]},"reference":[{"key":"9287_CR1","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1128\/IAI.73.4.2123-2128.2005","volume":"73","author":"GR Moe","year":"2005","unstructured":"Moe, G.R., Dave, A., Granoff, D.M.: Epitopes recognized by a non-autoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibody. Infect. Immun. 73, 2123\u20132128 (2005)","journal-title":"Infect. Immun."},{"key":"9287_CR2","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1084\/jem.185.11.1929","volume":"185","author":"RA Pon","year":"1997","unstructured":"Pon, R.A., Lussier, M., Yang, Q.L., Jennings, H.J.: N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis. J. Exp. Med. 185, 1929\u20131938 (1997)","journal-title":"J. Exp. Med."},{"key":"9287_CR3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0264-410X(02)00591-1","volume":"21","author":"J Holst","year":"2003","unstructured":"Holst, J., Feiring, B., Fuglesang, J.E., Hoiby, E.A., Nokleby, H., Aaberge, I.S., Rosenqvist, E.: Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease. Vaccine 21, 734\u2013737 (2003)","journal-title":"Vaccine"},{"key":"9287_CR4","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","volume":"23","author":"P Oster","year":"2005","unstructured":"Oster, P., Lennon, D., O\u2019Hallahan, J., Mulholland, K., Reid, S., Martin, D.: MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 23, 2191\u20132196 (2005)","journal-title":"Vaccine"},{"key":"9287_CR5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/IAI.72.1.345-351.2004","volume":"72","author":"Y Li","year":"2004","unstructured":"Li, Y., Sun, Y.H., Ison, C., Levine, M.M., Tang, C.M.: Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live meningococci. Infect. Immun. 72, 345\u2013351 (2004)","journal-title":"Infect. Immun."},{"key":"9287_CR6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1586\/14760584.4.3.373","volume":"4","author":"A Gorringe","year":"2005","unstructured":"Gorringe, A.: Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease? Expert Rev. Vaccines 4, 373\u2013379 (2005)","journal-title":"Expert Rev. Vaccines"},{"key":"9287_CR7","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","volume":"287","author":"M Pizza","year":"2000","unstructured":"Pizza, M., Scarlato, V., Masignani, V., Giuliani, M.M., Arico, B., Comanducci, M., et al.: Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816\u20131820 (2000)","journal-title":"Science"},{"key":"9287_CR8","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.vaccine.2005.01.055","volume":"23","author":"A Gorringe","year":"2005","unstructured":"Gorringe, A., Halliwell, D., Matheson, M., Reddin, K., Finney, M., Hudson, M.: The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Vaccine 23, 2210\u20132213 (2005)","journal-title":"Vaccine"},{"key":"9287_CR9","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1016\/j.vaccine.2004.02.014","volume":"22","author":"CL Vermont","year":"2004","unstructured":"Vermont, C.L., Van Dijken, H.H., De Groot, R., Van Alphen, L., Van Den Dobblestein, G.P.: PorA- specific differences in antibody avidity after vaccination with a hexavalent menB outer membrane vesicle vaccine in toddlers and school children. Vaccine 22, 3008\u20133013 (2004)","journal-title":"Vaccine"},{"key":"9287_CR10","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","volume":"103","author":"MM Giuliani","year":"2006","unstructured":"Giuliani, M.M., Adu-Bobie, J., Comanducci, M., Arico, B., Savino, S., Santini, L., et al.: A universal vaccine for serogroup B meningococcus. PNAS 103, 10834\u201310839 (2006)","journal-title":"PNAS"},{"key":"9287_CR11","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1128\/IAI.67.10.5417-5426.1999","volume":"67","author":"JS Plested","year":"1999","unstructured":"Plested, J.S., Makepeace, K., Jennings, M.P., Gidney, M.A., Lacelle, S., Brisson, J.R., Cox, A.D., et al.: Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis. Infect. Immun. 67, 5417\u20135426 (1999)","journal-title":"Infect. Immun."},{"key":"9287_CR12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1086\/368360","volume":"187","author":"JS Plested","year":"2003","unstructured":"Plested, J.S., Harris, S.L., Wright, J.C., Coull, P.A., Makepeace, K., Gidney, M.A.J., et al.: Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia. J. Infect. Dis. 187, 1223\u20131234 (2003)","journal-title":"J. Infect. Dis."},{"key":"9287_CR13","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1016\/j.vaccine.2005.06.011","volume":"23","author":"AD Cox","year":"2005","unstructured":"Cox, A.D., Zou, W., Gidney, M.A.J., Lacelle, S., Plested, J.S., Makepeace, K., et al.: Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits. Vaccine 23, 5045\u20135054 (2005)","journal-title":"Vaccine"},{"key":"9287_CR14","unstructured":"Pavliak, V., et al.: Neisseria meningitidis LOS conjugate vaccine against meningococcal disease. 14th IPNC, Milwaukee, USA (2004)"},{"key":"9287_CR15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/IAI.72.1.559-569.2004","volume":"72","author":"MAJ Gidney","year":"2004","unstructured":"Gidney, M.A.J., Plested, J.S., Lacelle, S., Coull, P.A., Wright, J.C., Makepeace, K., et al.: Development, characterisation and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide (LPS) epitopes in Neisseria meningitidis. Infect. Immun. 72, 559\u2013569 (2004)","journal-title":"Infect. Immun."},{"key":"9287_CR16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2958.2002.02754.x","volume":"43","author":"FG Mackinnon","year":"2002","unstructured":"Mackinnon, F.G., Cox, A.D., Plested, J.S., Tang, C.M., Makepeace, K., Coull, P.A., et al.: Identification of a gene (lpt-3) required for the addition of phosphoethanolamine to the lipopolysaccharide inner core of Neisseria meningitidis and its role in mediating susceptibility to bactericidal killing and opsonophagocytosis. Mol. Microbiol. 43, 931\u2013943 (2002)","journal-title":"Mol. Microbiol."},{"key":"9287_CR17","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2008.09.041","volume":"26","author":"A J\u00e4kel","year":"2008","unstructured":"J\u00e4kel, A., Plested, J.S., Hoe, J.C., Makepeace, K., Gidney, M.A.J., Lacelle, S., et al.: Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures. Vaccine 26, 6655\u20136663 (2008)","journal-title":"Vaccine"},{"key":"9287_CR18","first-page":"88","volume":"5","author":"O Westphal","year":"1965","unstructured":"Westphal, O., Jann, K.: Bacterial lipopolysaccharide. Methods Carbohydr. Chem. 5, 88\u201391 (1965)","journal-title":"Methods Carbohydr. Chem."},{"key":"9287_CR19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., et al.: Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76\u201385 (1985)","journal-title":"Anal. Biochem."},{"key":"9287_CR20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/ac60111a017","volume":"28","author":"M Dubois","year":"1956","unstructured":"Dubois, M., Gilles, K.A., Hamilton, J.K., Rebers, P.A., Smith, F.: Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350\u2013356 (1956)","journal-title":"Anal. Chem."},{"key":"9287_CR21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/j.1460-2075.1982.tb01287.x","volume":"1","author":"M Claviez","year":"1982","unstructured":"Claviez, M., Pagh, K., Maruta, H., Baltes, W., Fisher, P., Gerisch, G.: Electron microscopic mapping of monoclonal antibodies on the tail region of Dictyostelium myosin. EMBO J. 1, 1017\u20131022 (1982)","journal-title":"EMBO J."},{"key":"9287_CR22","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1021\/ac60231a048","volume":"37","author":"DG Sawardeker","year":"1965","unstructured":"Sawardeker, D.G., Sloneker, J.H., Jeanes, A.: Quantitative determination of monosaccharides as their alditol acetates by gas liquid chromatography. Anal. Chem. 37, 1602\u20131604 (1965)","journal-title":"Anal. Chem."},{"key":"9287_CR23","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0008-6215(02)00161-1","volume":"337","author":"AD Cox","year":"2002","unstructured":"Cox, A.D., Li, J., Brisson, J.-R., Moxon, E.R., Richards, J.C.: Structural analysis of the lipopolysaccharide from Neisseria meningitidis strain BZ157 galE: localisation of two phosphoethanolamine residues in the inner core oligosaccharide. Carbohydr. Res. 337, 1435\u20131444 (2002)","journal-title":"Carbohydr. Res."},{"key":"9287_CR24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli, U.K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680\u2013685 (1970)","journal-title":"Nature"},{"key":"9287_CR25","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1073\/pnas.96.9.5194","volume":"96","author":"V Pozsgay","year":"1999","unstructured":"Pozsgay, V., Chu, C., Pannell, L., Wolfe, J., Robbins, J.B., Schneerson, R.: Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1. PNAS 96, 5194\u20135197 (1999)","journal-title":"PNAS"},{"key":"9287_CR26","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1016\/S0021-9258(18)50501-9","volume":"254","author":"MR Rosner","year":"1979","unstructured":"Rosner, M.R., Verret, R.C., Khorana, H.G.: The structure of lipopolysaccharide from an Escherichia coli heptose-less mutant. III. Two fatty acid amidases from Dictyostelium discoideum and their action on lipopolysaccharide derivatives. J. Biol. Chem. 254, 5926\u20135933 (1979)","journal-title":"J. Biol. Chem."}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-010-9287-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10719-010-9287-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-010-9287-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T05:36:49Z","timestamp":1635140209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10719-010-9287-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,26]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["9287"],"URL":"https:\/\/doi.org\/10.1007\/s10719-010-9287-0","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"value":"0282-0080","type":"print"},{"value":"1573-4986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,26]]}}}